학술논문
Health-related quality-of-life results from the randomised phase II TAVAREC trial on temozolomide with or without bevacizumab in 1p/19q intact first-recurrence World Health Organization grade 2 and 3 glioma (European Organization for Research and Treatment of Cancer 26091)
Document Type
Article
Author
Source
In European Journal of Cancer September 2023 190
Subject
Language
ISSN
0959-8049